Cortex Pharmaceuticals

Cortex Pharmaceuticals Incorporated is a development stage enterprise that was organized in 1987 to engage in the discovery, development and commercialization of innovative pharmaceuticals for the treatment of neurodegenerative diseases and other neurological and psychiatric disorders. Since 1993, the primary effort at Cortex has been centered on developing products that affect the AMPA-type glutamate receptor, a complex of proteins that is involved in most "excitatory" communication between nerve cells in the human brain. Cortex is developing a family of chemical compounds, knownas Ampakines/(R)/, that enhance the activity of this receptor. Cortex believes that Ampakines hold promise for correcting deficits brought on by a variety of diseases and disorders that are known, or thought, to involve depressed functioning of pathways in the brain that use glutamate as a neurotransmitter.

Contact Details: 15231 Barranca Parkway Irvine CA 92618 United States of America Tel: 714 727 3157 Fax: 714 727 3657 Email: info@cortexpharm.com WWW: www.cortexpharm.com/

Loading...

Recent Publications by Cortex Pharmaceuticals:
Randomized, double-blind, placebo-controlled international clinical trial of the Ampakine CX516 in elderly participants with mild cognitive impairment: a progress report. This progress report briefly describes the rationale and study design for...	29th January, 2003	Cortex Pharmaceuticals, Inc., Irvine, CA 92618, USA.	J Mol Neurosci. 2002 Aug-Oct;19(1-2):197-200.
Amyloid beta protein is internalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor protein. A critical issue concerning Alzheimer's disease is its selectivity, which...	20th June, 2000	Cortex Pharmaceuticals, Inc., Irvine, California 92618, USA.	J Comp Neurol. 1998 Jul 20;397(1):139-47.

BioNews Results for Cortex Pharmaceuticals:
Valeant Announces Presentation of Retigabine Data at the 8th European Congress on Epileptology	Pharma Live:  Sep 17 2008 12:04AM Matching: cortex pharmaceuticals
Valeant Announces Presentation of Retigabine Data at the 8th European Congress on Epileptology	Genetic Engineering News:  Sep 15 2008 11:21PM Matching: cortex pharmaceuticals
CORTEX PHARMACEUTICALS INC Consensus Recommendation: STRONG BUY	Macro World Investor:  Sep 12 2008 5:14PM Matching: cortex pharmaceuticals
Rodman & Renshaw Changes EPS Estimate of CORTEX PHARMACEUTICALS INC: Current Recommendation is Market Outperfo	Calibre Macro World:  Sep 12 2008 5:31PM Matching: cortex pharmaceuticals
Rodman & Renshaw Changes EPS Estimate of CORTEX PHARMACEUTICALS INC: Current Recommendation is Market Outperfo	Macro World Investor:  Sep 12 2008 5:14PM Matching: cortex pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution	→View more Cortex Pharmaceuticals news.

Cortex Pharmaceuticals Patents:
US Patent No.	Title
6166008	Treatment of schizophrenia with ampakines and neuroleptics
5985871	Benzoxazine compounds for enhancing synaptic response
5736543	Benzoxazines for enhancing synaptic response
5650409	Benzoyl piperidines/pyrrolidines for enhancing synaptic response
5622981	Use of metabotropic receptor agonists in progressive neurodegenerative diseases
→View more Cortex Pharmaceuticals patents.

Cortex Pharmaceuticals (COR) Financial information Links from Barchart
COR Quote from from Barchart.com
COR Chart from from Barchart.com
COR Profile from from Barchart.com
COR Opinion from from Barchart.com
→View more Cortex Pharmaceuticals finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 184 times since April 2007, the link to the organisation's website has been followed 34 times

Recent Search Terms used to find this page: info cortexpharm com | cortex | cortex | cortex | .

Search for more companies in Irvine

Search for more companies in CA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Cortex Pharmaceuticals